Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT) -- Ignore unavailable to you. Want to Upgrade?

To: Dennis who wrote (390)	2/2/1999 11:52:00 PM
From: Mike	Read Replies (4) \| Respond to of 687

I still love the target on MDT of $100. We have moved fast and hard in the past week. We may or may not give some back. The momentum will be determined by the earnings that will be released on there third qtr sales that ended Jan 31. Two other pieces of the MDT puzzle that everyone will have to look for is the following: 1. FDA approval on the AVEI GFX II stent- this will be a very big approval for AVE division of MDT. 2. FDA approval on the SDG cage. This is also a very important product for the SDG division of MDT. Does anyone else have any other milestones or approvals that we should be looking out for? Thanks, Mike